BACE1 inhibitor drugs for the treatment of Alzheimer's disease: Lessons learned, challenges to overcome, and future prospects†
Global Health & Medicine · 30.06.2024 · 6 (3) · 164-169
DOI: 10.35772/ghm.2024.01033 ↗Kurz gefasst
Editorial in der Zeitschrift Global Health & Medicine, erschienen am 30.06.2024. Verfasst von Arun K Ghosh. Beteiligte Einrichtung: Departments of Chemistry, Purdue University, West Lafayette, IN, USA. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Themen: Demenz
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Departments of Chemistry, Purdue University, West Lafayette, IN, USA.
- Department of Medicinal Chemistry and Molecular Pharmacology, Purdue University, West Lafayette, IN, USA.
Zitieren
APA
Ghosh, A. K. (2024). BACE1 inhibitor drugs for the treatment of Alzheimer's disease: Lessons learned, challenges to overcome, and future prospects†. Global Health & Medicine, 6(3), 164-169. https://doi.org/10.35772/ghm.2024.01033
Vancouver
Ghosh AK. BACE1 inhibitor drugs for the treatment of Alzheimer's disease: Lessons learned, challenges to overcome, and future prospects†. Global Health & Medicine. 2024;6(3):164-169. doi:10.35772/ghm.2024.01033
BibTeX
@article{Ghosh2024,
author = {Ghosh, Arun K},
title = {BACE1 inhibitor drugs for the treatment of Alzheimer's disease: Lessons learned, challenges to overcome, and future prospects†},
journal = {Global Health & Medicine},
year = {2024},
volume = {6},
number = {3},
pages = {164--169},
doi = {10.35772/ghm.2024.01033}
}
EUVIMED